LiA Report: Exploring Cardiovascular Bioengineering and Protein-based Antibodies for the Treatment of Heart Rhythm Disorders in Cambridgeshire Communities
This summer I undertook my LiA with Maxion Therapeutics in Sawston. This project had a two-pronged approach: to ask how bioengineering can made meaningful to the communities most affected by heart rhythm disorders.